Is 1047 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 1047 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 1047's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 1047's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 1047?
Key metric: As 1047 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for 1047. This is calculated by dividing 1047's market cap by their current
revenue.
What is 1047's PS Ratio?
PS Ratio
0.09x
Sales
HK$1.28b
Market Cap
HK$119.99m
1047 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: 1047 is good value based on its Price-To-Sales Ratio (0.1x) compared to the Hong Kong Chemicals industry average (0.4x).
Price to Sales Ratio vs Fair Ratio
What is 1047's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
1047 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
0.09x
Fair PS Ratio
n/a
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 1047's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.